NK cell

Antibody-mediated killing using NK cells, which are NK cells engineered to incorporate a high binding affinity receptor that binds to an administered antibody, enhancing the cancer cell killing effect of that antibody.

NKT cell

Antibody-mediated killing using NK cells, which are NK cells engineered to incorporate a high binding affinity receptor that binds to an administered antibody, enhancing the cancer cell killing effect of that antibody.

CD8+ T cell

Our newest line of investigational products are an innovative combination of our CD8+ T cell and NK cell platforms in a single genetic engineered platform that incorporates all the features of our NK cell platform together with a CAR with the resulting

previous arrow
next arrow
Slider

Immunotherapeutic vaccine

Vaccines are usually prophylactic.
The purpose of vaccination is to prevent future infections
by providing active acquired immunity (immunologic memory) to a particular disease.
In contrast, immunotherapeutic vaccines are administered to patients who already have diseases.
Immunotherapeutic vaccines treat various infectious
diseases and cancers through enhancing patients’ immune responses.
NATURAL KILLER CELLS: THE QUEST TOWARDS A CURE
OUR WAR AGAINST CANCER
Harnessing Nature’s Immune System
Slider
The World’s First Off The Shelf Genetically Engineered Natural Killer Cell Platform
Meet our NK Cells
Slider

DrHarvard™ Platform Technology

DrHarvard immunotherapeutic vaccine is a personalized medicine that uses patient’s own cells (autologous immune cells). It helps patient’s immune system to find out and eliminate cancer cells.
DrHarvard is composed of three parts: Antigen presenting cells (APCs), tumor-associated antigen genes, and adjuvant.
It uses autologous lymphocytes (patient’s B cells & monocytes) as APCs. APCs process foreign antigens and/or impaired cells into peptide fragments and present them to immune cells.
APCs of DrHarvard have tumor-specific antigen genes. They present tumor antigens to immune cells and activate them to eliminate specific tumor cells.
α-galactosylceramide is an adjuvant which potentiate the anti-tumor activities of DrHarvard.
Tumor cells overexpress specific tumor antigens on their surface and by changing the inserted tumor antigen genes, DrHarvard can be used for various cancers.
DrHarvard is a platform technology that can be applied to every cancer with identified tumor antigen.
DrHARVARD

Dr HARVARD is a R&D specialized bioventure company started in a laboratory in the college of pharmacy, Harvard University.
We are developing innovative immunotherapeutic vaccines, Cellon, that can overcome the medical and technical limitations of current cancer and/or infectious diseases therapies.
Cellon is a personalized vaccine which uses patient’s own cells.
It is a powerful and efficient immunotherapeutic vaccine that activates all types of immune cells usable in our immune system with minimum adverse effects.
Our goal is to improve the quality of life of patients suffering from intractable diseases.

MISSION

To develop personalized immunotherapeutic vaccines for patients with cancers or infectious diseases
that are hard to treat due to medical & technical limitations.
· To introduce new paradigm for immunotherapeutic
vaccines and improve quality of life of patients treated.

VISION

To improve technology through consistent research and development
· To become a global leading biotech-company.

Slider

Subscribe to stay up to date on the Dr Harvard

Email*

We won’t send you spam. Unsubscribe at any time.

A member of the DrHarvard ecosystem of companies Privacy Policy | Legal Notice

Natural Killer Cells (NK cells), Natural Killer T cells (NKT cells), helper T cells, Antibodies (Abs) are trademarks or registered trademarks of DrHARVAR

Natural Killer Cell platform consists of investigational agents that are restricted by federal law to investigational use only.

 Natural Killer Cell platform is being investigated in multiple clinical trials across tumor sites.
The content of this website is protected by Title 17 of the U.S. Code and may not be reproduced in whole or in part by any means.